Nombre del producto:4,5,6,7-tetradeuterio-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

IUPAC Name:2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro(²H₄)-1H-isoindole-1,3-dione

CAS:1219177-18-0
Fórmula molecular:C13H6D4N2O4
Pureza:95%+
Número de catálogo:CM340807
Peso molecular:262.26

Unidad de embalaje Stock disponible Precio($) Cantidad
CM340807-10mg 5-6 Weeks țƦƦƦ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1219177-18-0
Fórmula molecular:C13H6D4N2O4
Punto de fusión:-
Código de sonrisas:O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C([2H])=C([2H])C([2H])=C3[2H])=O
Densidad:
Número de catálogo:CM340807
Peso molecular:262.26
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products